The company has also filed a patent application dated this month for the process that allows Zinc Fingered Proteins to upregulate genes that produce Neurotropic Factor 3 proteins (NT 3) and Glial Cell Line-Derived Neurotrophic Factor (GNDF). Deficiency in the former is prevalent in many different types of PN including CMTand Diabetic PN and the latter is involved in Parkinson's Disease. This is incredibly exciting stuff that may prove to be the next generation treatments we have all been hoping for. This should give hope that some of our suffering may be treatable in the near future.